Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Bergqvist, D.
space
  arrow  Odegaard, K.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

Cost of Long-Term Complications of Deep Venous Thrombosis of the Lower Extremities: An Analysis of a Defined Patient Population in Sweden

right arrow David Bergqvist, PhD, MD; Stefan Jendteg, BSc; Lars Johansen, MD; Ulf Persson, PhL, MPolSci; and Knut Odegaard, PhD

15 March 1997 | Volume 126 Issue 6 | Pages 454-457

Background: Little information is available on the epidemiology and economic effect of long-term complications developing after deep venous thrombosis.

Objective: To determine the extent of, timing of, and treatment costs associated with long-term complications developing after deep venous thrombosis of the lower extremities.

Design: 15-year retrospective cohort study.

Setting: County hospital in Sweden.

Patients: 257 patients with deep venous thrombosis and 241 age- and sex-matched controls without deep venous thrombosis.

Measurements: Data on use of health care resources and costs of inpatient and outpatient care, pharmaceutical agents, and treatment of complications.

Results: After 15 years of follow-up, 35% of the patients with thrombosis and 57% of the controls were alive. Two hundred forty-two complications were reported among the patients with thrombosis, and 25 similar events were reported among the controls. The average expected present value of the health care cost of treating complications of thrombosis was estimated to be about $4659 in the patients with thrombosis and $375 in the controls. In controls, primary deep venous thrombosis cost about $6000; thus, the additional long-term health care cost of post-thrombotic complications is about 75% of the cost of primary deep venous thrombosis.

Conclusions: The economic effect of post-thrombotic complications is considerable. The use of measures to prevent thromboembolism and its long-term complications are justified on both clinical and economic grounds.

Author and Article Information
space

From University Hospital, Uppsala, Sweden; Institute of Health Economics, Lund, Sweden; and Skovde Hospital, Skovde, Sweden.
Acknowledgment: The authors thank Eva-Karin Johansson, RN, for compiling patient data and providing medical judgments.
Grant Support: In part by Ciba-Geigy Limited, grant 00759 from the Swedish Medical Research Council, and the Swedish Heart and Lung Foundation.
Requests for Reprints: Lars Johansen, MD, Department of Surgery, Skovde Hospital, S-541 85 Skovde, Sweden.
Current Author Addresses: Dr. Bergqvist: Department of Surgery, University Hospital, S-751 85 Uppsala, Sweden.




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
D. A. MacDougall, A. L. Feliu, S. J. Boccuzzi, and J. Lin
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome.
Am. J. Health Syst. Pharm., October 15, 2006; 63(20 Suppl 6): S5 - S15.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
P. Tilleul, A. LaFuma, X. Colin, and Y. Ozier
Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in france.
Clinical and Applied Thrombosis/Hemostasis, October 1, 2006; 12(4): 473 - 484.
[Abstract] [PDF]


Home page
ChestHome page
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 338S - 400S.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. Prandoni, A. W.A. Lensing, M. H. Prins, M. Frulla, A. Marchiori, E. Bernardi, D. Tormene, L. Mosena, A. Pagnan, and A. Girolami
Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome: A Randomized, Controlled Trial
Ann Intern Med, August 17, 2004; 141(4): 249 - 256.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. R. Kahn and J. S. Ginsberg
Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome
Arch Intern Med, January 12, 2004; 164(1): 17 - 26.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. E. Cox, S. S. Carson, and A. K. Biddle
Cost-effectiveness of Ultrasound in Preventing Femoral Venous Catheter-associated Pulmonary Embolism
Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. L. Davidson, S. D. Sullivan, S. R. Kahn, L. Borris, P. Bossuyt, and G. Raskob
The Economics of Venous Thromboembolism Prophylaxis: A Primer for Clinicians
Chest, December 1, 2003; 124(6_suppl): 393S - 396S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. A. Heit
The Potential Role of Direct Thrombin Inhibitors in the Prevention and Treatment of Venous Thromboembolism
Chest, September 1, 2003; 124(3_suppl): 40S - 48S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. W. Raymond
Getting a Leg Up on the Postthrombotic Syndrome
Chest, February 1, 2003; 123(2): 327 - 330.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. A. Heit
The Potential Role of Fondaparinux as Venous Thromboembolism Prophylaxis After Total Hip or Knee Replacement or Hip Fracture Surgery
Arch Intern Med, September 9, 2002; 162(16): 1806 - 1808.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. A. Heit, W. M. O'Fallon, T. M. Petterson, C. M. Lohse, M. D. Silverstein, D. N. Mohr, and L. J. Melton III
Relative Impact of Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Study
Arch Intern Med, June 10, 2002; 162(11): 1245 - 1248.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Obernosterer, M. Aschauer, W. Schnedl, and R. W. Lipp
Anomalies of the Inferior Vena Cava in Patients with Iliac Venous Thrombosis
Ann Intern Med, January 1, 2002; 136(1): 37 - 41.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. A. Heit, D. N. Mohr, M. D. Silverstein, T. M. Petterson, W. M. O'Fallon, and L. J. Melton III
Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Cohort Study
Arch Intern Med, March 27, 2000; 160(6): 761 - 768.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Etchells, R. S. McLeod, W. Geerts, P. Barton, and A. S. Detsky
Economic Analysis of Low-Dose Heparin vs the Low-Molecular-Weight Heparin Enoxaparin for Prevention of Venous Thromboembolism After Colorectal Surgery
Arch Intern Med, June 14, 1999; 159(11): 1221 - 1228.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. K. Gould, A. D. Dembitzer, G. D. Sanders, and A. M. Garber
Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis
Ann Intern Med, May 18, 1999; 130(10): 789 - 799.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. W Olin, K. M Beusterien, M. B. Childs, C. Seavey, L. McHugh, and R. I Griffiths
Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study
Vascular Medicine, February 1, 1999; 4(1): 1 - 7.
[Abstract] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.